scholarly article | Q13442814 |
P2093 | author name string | Mohamed A Khalil | |
Abdelhay A Ebade | |||
Ahmed K Mohamed | |||
P2860 | cites work | Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies | Q28249459 |
Myocardial efficiency during levosimendan infusion in congestive heart failure. | Q31647357 | ||
Unidirectional valved patch closure of ventricular septal defects with severe pulmonary arterial hypertension | Q35961813 | ||
Management strategies for patients with pulmonary hypertension in the intensive care unit | Q36940493 | ||
Levosimendan reduces mortality in critically ill patients. A meta-analysis of randomized controlled studies. | Q37717988 | ||
Levosimendan in the treatment of cardiogenic shock. | Q37799518 | ||
Pulmonary vascular disease with congenital heart lesions: pathologic features and causes | Q39566087 | ||
Intensive care for newborns and babies of the first year of life with acute heart failure after cardiosurgical interventions | Q42746134 | ||
Use of levosimendan in cardiosurgical patients with chronic heart insufficiency | Q43044437 | ||
Acute hemodynamic effects of inhaled nitroglycerine, intravenous nitroglycerine, and their combination with intravenous dobutamine in patients with secondary pulmonary hypertension | Q43074088 | ||
Effect of different pharmacologic agents to reverse severe pulmonary hypertension among end-stage heart failure patients. | Q43283968 | ||
Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial. | Q44297394 | ||
Successful treatment of dilative cardiomyopathy in a 12-year-old girl using the calcium sensitizer levosimendan after weaning from mechanical biventricular assist support | Q45224330 | ||
Weaning difficult-to-wean chronic obstructive pulmonary disease patients: a pilot study comparing initial hemodynamic effects of levosimendan and dobutamine | Q46187787 | ||
Levosimendan versus an intra-aortic balloon pump in high-risk cardiac patients. | Q46422969 | ||
Levosimendan vs. intra-aortic balloon pump in high-risk cardiac surgery. | Q48273297 | ||
Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium | Q48750045 | ||
Levosimendan reduces heart failure after cardiac surgery: a prospective, randomized, placebo-controlled trial. | Q51027720 | ||
Levosimendan in Congenital Cardiac Surgery: A Randomized, Double-Blind Clinical Trial | Q51752502 | ||
Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure. | Q53901244 | ||
Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes. | Q53965064 | ||
Are transoesophageal Doppler parameters a reliable guide to paediatric haemodynamic status and fluid management? | Q54014530 | ||
Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. | Q54137481 | ||
Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs. | Q54167403 | ||
Myocardial efficiency during calcium sensitization with levosimendan: A noninvasive study with positron emission tomography and echocardiography in healthy volunteers* | Q57623335 | ||
Levosimendan attenuates pulmonary vascular remodeling | Q60722882 | ||
Pulmonary artery endothelial abnormalities in patients with congenital heart defects and pulmonary hypertension. A correlation of light with scanning electron microscopy and transmission electron microscopy | Q69668980 | ||
Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series | Q80295708 | ||
P433 | issue | 3 | |
P921 | main subject | pulmonary hypertension | Q1128595 |
P304 | page(s) | 334-339 | |
P577 | publication date | 2012-12-09 | |
P1433 | published in | Journal of Anesthesia | Q2308373 |
P1476 | title | Levosimendan is superior to dobutamine as an inodilator in the treatment of pulmonary hypertension for children undergoing cardiac surgery | |
P478 | volume | 27 |
Q102209087 | An evidence-based review of the use of vasoactive and inotropic medications in post-operative paediatric patients after cardiac surgery with cardiopulmonary bypass from 2000 to 2020 |
Q38588160 | Critical care for paediatric patients with heart failure |
Q97884755 | Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use |
Q58781484 | Levosimendan for Pediatric Anomalous Left Coronary Artery From the Pulmonary Artery Undergoing Repair: A Single-Center Experience |
Q51760678 | Levosimendan for Perioperative Cardioprotection: Myth or Reality? |
Q89443434 | Levosimendan in pulmonary hypertension and right heart failure |
Q24629274 | Levosimendan: current data, clinical use and future development |
Q57689718 | Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease |
Q38644872 | Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease. |
Q48380637 | The Perspective of the Intensivist on Inotropes and Postoperative Care Following Pediatric Heart Surgery: An International Survey and Systematic Review of the Literature |
Q47237484 | Use of Levosimendan in Cardiac Surgery: An Update After the LEVO-CTS, CHEETAH, and LICORN Trials in the Light of Clinical Practice. |